Topical products: Aiming for quality, simplicity, and cost-efficiency in their development, scale-up, and manufacturing
Pharmaceutical Technology
JANUARY 6, 2023
It is important for a CDMO to understand the market it serves and, in the dermatologic arena, that means the demand for topical agents across a broad array of indications. In vitro release testing to demonstrate bioequivalence. Microbial bioassay – measures the potency of a biological active substance (e.g., Simplicity matters.
130 
Let's personalize your content